Table 5:
In-hospital outcome
| TMA (n = 11) | Non-TMA (n = 236) | P-value | |
|---|---|---|---|
| Operative mortalitya | 0 (–) | 13 (6) | 1.000 |
| Neurological outcome | |||
| Neurological disorders | 8 (73) | 70 (30) | 0.005 |
| Focal neurological deficits | 1 (9) | 12 (5) | 0.455 |
| Delirium | 5 (46) | 43 (18) | 0.041 |
| Delayed awakening | 2 (18) | 18 (8) | 0.220 |
| Renal outcome | |||
| Postoperative dialysis | 9 (82) | 30 (13) | <0.001 |
| Haemodialysis @ discharge | 0 (–) | 11 (5) | 1.000 |
| Morbidities | |||
| Re-exploration d/t bleeding | 3 (27) | 13 (6) | 0.027 |
| Postoperative v-a ECMO | 1 (9) | 11 (5) | 0.429 |
| Multiple organ failure | 3 (27) | 22 (9) | 0.088 |
| Catecholamines | |||
| Adrenalin (mg/h) | 0.2 (0–0.4) | 0.35 (0–0.6) | 0.086 |
| Noradrenalin (mg/h) | 0.7 (0.2–1) | 1.1 (0.5–2.1) | 0.105 |
| Vasopressin (IE/h) | 0 (0–0.5) | 0.5 (0–1.5) | 0.079 |
Data are shown as n (%) or median (0.25–0.75 percentile), bold: statistically significant.
a
Classified as in-hospital mortality plus 30-day mortality of discharged patients.
TMA: thrombotic microangiopathy; v-a ECMO: veno-arterial extracorporeal membrane oxygenation.